Remember, this is an Option Agreement to license,
Post# of 30029
Posted On: 08/06/2014 4:55:22 PM
Re: SouthBreeze #3195
Remember, this is an Option Agreement to license, not a License Agreement. This agreement gives Amarantus the exclusive option to license the IP for a period of 12 months. If the two parties cannot reach a mutually agreeable licensing arrangement, then I believe the option to license could be rescinded by either party. This is just my reasonable expectation, as I haven't seen the actual contract.
Given the company's licensing of LymPro from the same researcher, this seems like a highly promising combination going forward. I expect both parties understand this and will reach a licensing arrangement that beneficial to both.
Given the company's licensing of LymPro from the same researcher, this seems like a highly promising combination going forward. I expect both parties understand this and will reach a licensing arrangement that beneficial to both.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼